title: Fragility fracture: recent developments in risk assessment.
abstract: More than half of older women who sustain a fragility fracture do not have osteoporosis by World Health Organization (WHO) bone mineral density (BMD) criteria; and, while BMD has been used to assess fracture risk for over 30 years, a range of other skeletal and nonskeletal clinical risk factors (CRFs) for fracture have been recognized. More than 30 assessment tools using CRFs have been developed, some predicting fracture risk and others low BMD alone. Recent systematic reviews have reported that many tools have not been validated against fracture incidence, and that the complexity of tools and the number of CRFs included do not ensure best performance with poor assessment of (internal or comparative) validity. Internationally, FRAX® is the most commonly recommended tool, in addition to QFracture in the UK, The Canadian Association of Radiologists and Osteoporosis Canada (CAROC) tool in Canada and Garvan in Australia. All tools estimate standard 10-year risk of major osteoporotic and 10-year risk of hip fracture: FRAX® is able to estimate fracture risk either with or without BMD, but CAROC and Garvan both require BMD and QFracture does not. The best evidence for the utility of these tools is in case finding but there may be future prospects for the use of 10-year fracture risk as a common currency with reference to the benefits of treatment, whether pharmacological or lifestyle. The use of this metric is important in supporting health economic analyses. However, further calibration studies will be needed to prove that the tools are robust and that their estimates can be used in supporting treatment decisions, independent of BMD.
authors: Musculoskeletal Unit, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK and Newcastle University Framlington Place Newcastle upon Tyne NE2 4AB, UK.
authors: Terry J
authors: TJ
authors: Aspray
keywords: FRAX®; Garvan; QFracture; fracture risk assessment; osteoporosis; postmenopausal women
references: Osteoporos Int. 2013 Mar;24(3):941-7
references: 22872068
references: Osteoporos Int. 2013 Jan;24(1):23-57
references: 23079689
references: Lancet. 1990 Aug 4;336(8710):265-9
references: 1973969
references: Osteoporos Int. 2009 Oct;20(10):1675-82
references: 19291344
references: J Clin Densitom. 2005 Winter;8(4):371-8
references: 16311420
references: CMAJ. 2010 Nov 23;182(17):1864-73
references: 20940232
references: South Med J. 2001 Jun;94(6):569-73
references: 11440324
references: J Bone Miner Res. 2011 Mar;26(3):460-7
references: 20839285
references: Curr Osteoporos Rep. 2012 Sep;10(3):199-207
references: 22688862
references: Osteoporos Int. 2012 Nov;23(11):2567-76
references: 22270857
references: Osteoporos Int. 2011 Nov;22(11):2799-807
references: 21234548
references: Osteoporos Int. 2012 Sep;23(9):2257-76
references: 22434203
references: Osteoporos Int. 2012 Jan;23(1):75-85
references: 21850546
references: Curr Osteoporos Rep. 2010 Dec;8(4):192-7
references: 20811963
references: Osteoporos Int. 2013 Feb;24(2):681-8
references: 22736068
references: J Osteoporos. 2011;2011:924595
references: 21826255
references: Osteoporos Int. 2011 Jun;22(6):1873-83
references: 20967422
references: World Health Organ Tech Rep Ser. 1994;843:1-129
references: 7941614
references: Curr Opin Rheumatol. 2012 Sep;24(5):554-60
references: 22820516
references: Menopause. 2011 Jan;18(1):53-9
references: 20711081
references: J Clin Densitom. 2001 Winter;4(4):373-80
references: 11748342
references: Breast Cancer Res Treat. 2012 Jun;133(3):1089-96
references: 22453753
references: J Bone Miner Res. 2008 Oct;23(10):1561-8
references: 18505372
references: Osteoporos Int. 2008 Apr;19(4):437-47
references: 18292976
references: Osteoporos Int. 2014 May;25(5):1439-43
references: 24577348
references: BMJ. 2007 Jul 21;335(7611):136
references: 17615182
references: BMJ. 2012 May 22;344:e3427
references: 22619194
references: BMJ. 2012 Aug 08;345:e3698
references: 22875946
references: J Bone Miner Res. 2012 Feb;27(2):301-8
references: 22052532
references: Osteoporos Int. 2014 Jan;25(1):23-49
references: 24105431
references: Osteoporos Int. 2012 Oct;23(10):2507-15
references: 22314936
references: Bonekey Rep. 2014 Jun 25;3:542
references: 24991405
references: Osteoporos Int. 2009 May;20(5):811-7
references: 19002369
references: Osteoporos Int. 2008 Jul;19(7):895-903
references: 18071648
references: J Clin Densitom. 2010 Apr-Jun;13(2):141-6
references: 20435264
references: Bone. 2003 Oct;33(4):505-13
references: 14555253
references: J Bone Miner Res. 2013 Aug;28(8):1701-17
references: 23592255
references: J Bone Miner Res. 2011 Feb;26(2):420-7
references: 20721930
references: Osteoporos Int. 2007 Aug;18(8):1033-46
references: 17323110
references: Osteoporos Int. 2005 Jun;16(6):581-9
references: 15616758
references: Urol Clin North Am. 2004 May;31(2):331-52
references: 15123412
references: J Bone Miner Res. 2010 Nov;25(11):2350-8
references: 20499367
references: J Bone Miner Res. 1994 Aug;9(8):1137-41
references: 7976495
references: Am J Med. 1997 Aug 18;103(2A):3S-8S; discussion 8S-11S
references: 9302892
references: Age Ageing. 2013 Sep;42(5):548-54
references: 23892830
references: Osteoporos Int. 1991 Feb;1(2):114-7
references: 1790392
references: Curr Opin Rheumatol. 2013 Jul;25(4):532-41
references: 23656708
references: Cancer Treat Rev. 2008;34 Suppl 1:S3-18
references: 18515009
references: Osteoporos Int. 2008 Apr;19(4):385-97
references: 18292978
references: Natl Inst Health Consens Dev Conf Consens Statement. 1984;5(3):6 p.
references: 6398406